ViewsIQ’s vision is to augment clinical diagnosis by connecting pathologists in real-time to cost-efficiently speed diagnosis and improve patient outcomes. ViewsIQ has a proprietary software platform called Panoptiq that enables one to digitize samples microscopically, without disrupting existing workflows. To realize the company’s vision, ViewsIQ is augmenting these advantages with AI-driven cancer detection and classification algorithms.